Ventas, Inc. with ticker code (VTR) have now 17 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $60.00 and $47.00 with the average target price sitting at $52.00. Given that the stocks previous close was at $48.68 and the analysts are correct then there would likely be a percentage uptick in value of 6.8%. The 50 day MA is $46.30 and the 200 moving average now moves to $45.09. The company has a market capitalization of 19.60B. The stock price is currently at: $48.71 USD
The potential market cap would be $20,936,706,693 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 2435.5, revenue per share of $10.87 and a 1.58% return on assets.
Ventas, Inc. is a real estate investment trust (REIT). The Company is engaged in operating at the intersection of healthcare and real estate. It has a portfolio of senior housing communities, medical office buildings (MOBs), life science, research and innovation centers, hospitals and other healthcare facilities. The Company’s segments include Triple-Net Leased Properties, Senior Housing Operating Portfolio (SHOP), and Office Operations. Triple-Net Leased Properties is engaged in investing in and owning senior housing and healthcare properties throughout the United States and the United Kingdom and leasing those properties to healthcare operating companies under triple-net or absolute-net leases. The Senior Housing Operating Portfolio (SHOP) segment invests in senior housing communities throughout the United States and Canada. The Office Operations segment acquires, owns, develops, leases and manages MOBs and life science, research and innovation centers throughout the United States.
